Holmberg L, Odar-Cederlöf I, Boréus L O, Heyner L, Ehrnebo M
Eur J Clin Pharmacol. 1982;22(2):175-9. doi: 10.1007/BF00542464.
Pethidine was given as a single intravenous dose for premedication before minor surgery. Two groups of subjects were studied, old patients aged more than 65 years, and young patients aged 18-30 years. Blood samples were taken at fixed intervals for 30 h after the injection, and the plasma concentrations of pethidine and its major metabolite norpethidine were analyzed by gas chromatography. In comparison with the young the old patients had a lower plasma clearance for pethidine (9.13 +/- 2.50 versus 16.18 +/- 5.15 ml/min/kg), slower elimination rate beta (0.101 +/- 0.036 versus 0.211 +/- 0.146), and a larger AUC (1935 +/- 554 versus 1092 +/- 277 h . ng/ml) but a similar volume of distribution (5.69 +/- 1.54 versus 5.38 +/- 1.75 l/kg). Norpethidine appeared later and reached its peak concentration later in the old patients than in the young. In several old patients it was still present at a plateau level after 30 h. The present study emphasizes that both parent drug and active metabolite must be taken into consideration when drug therapy is evaluated. The data do not provide pharmacokinetic support for a reduction in the dose of pethidine if it is given as a single intravenous dose. However, when repeatedly administered, it is advisable to reduce the total daily dose.
在小手术前,哌替啶作为单一静脉剂量用于术前用药。研究了两组受试者,65岁以上的老年患者和18 - 30岁的年轻患者。注射后30小时内按固定间隔采集血样,采用气相色谱法分析血浆中哌替啶及其主要代谢产物去甲哌替啶的浓度。与年轻患者相比,老年患者哌替啶的血浆清除率较低(9.13±2.50对16.18±5.15 ml/min/kg),消除速率β较慢(0.101±0.036对0.211±0.146),曲线下面积较大(1935±554对1092±277 h·ng/ml),但分布容积相似(5.69±1.54对5.38±1.75 l/kg)。老年患者去甲哌替啶出现时间较晚,达到峰值浓度的时间也比年轻患者晚。在一些老年患者中,30小时后仍维持在平台期水平。本研究强调,在评估药物治疗时,必须同时考虑母体药物和活性代谢产物。如果哌替啶作为单一静脉剂量给药,这些数据并未提供降低剂量的药代动力学依据。然而,反复给药时,建议减少每日总剂量。